Stromal Vascular Fraction Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (SVF Aspirate Purification Products, SVF Transfer Products, SVF Isolation Products); Application (Cosmetic Applications, Soft Tissue Applications, Orthopaedic Applications, Others); End-Users (Hospitals, Stem Cell Banks/Laboratories, Specialty Clinics, Others) and Geography

Report Code: TIPRE00021191 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Get Free Sample PDF
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Stromal vascular fraction (SVF) is a type of skin treatment method that is very crucial in regenerative medicine. It is based on stem cell therapy where cells are isolated from adipose tissue from patient's own body. SVF cells are obtained through liposuction and are of multiple types like adipose-derived stem cells, mesenchymal stem cells, endothelial cells, leukocytes, tissue containing fat cells etc. This method holds various helpful anti-ageing and regenerative properties. SVF injections are a great alternative in field of orthopaedics for musculoskeletal disorders treatment.

MARKET DYNAMICS

The growing prevalence of muscular disorders, increasing volume of cosmetic surgeries and increasing awareness about stem cell therapy are factors that are supposed to contribute to the global stromal vascular fraction market. Stromal vascular fraction is also used in treating various chronic disorders. A rising inclination towards value-based model of medical delivery and improved healthcare facilities worldwide are considered as driving factors for stromal vascular fraction market development.

MARKET SCOPE

The "Stromal Vascular Fraction Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of stromal vascular fraction market with detailed market segmentation by type, application and end-users. The stromal vascular fraction market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in stromal vascular fraction market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The stromal vascular fraction market is segmented on the basis of type, application and end-users. On the basis of type, the market is segmented SVF aspirate purification products, SVF transfer products and SVF isolation products. On the basis of application, the market is segmented as cosmetic applications, soft tissue applications, orthopedic applications and others. On the basis of end-users, the market is segmented as hospitals, stem cell banks/laboratories, specialty clinics and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the stromal vascular fraction market based on various segments. It also provides market size and forecast estimates from year 2018 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The stromal vascular fraction market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting stromal vascular fraction market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the stromal vascular fraction market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the stromal vascular fraction market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from stromal vascular fraction market are anticipated to have lucrative growth opportunities in the future with the rising demand for stromal vascular fraction in the global market. Below mentioned is the list of few companies engaged in the stromal vascular fraction market.

The report also includes the profiles of key players in stromal vascular fraction market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Cytori Therapeutics.
  •  Cellular Biomedicine Group, Inc.
  •  GE Healthcare.
  •  Medikan International.
  •  Ingeneron.
  •  Tissue Genesis.
  •  Genesis Biosystems.
  •  Human Med.
  •  IntelliCell BioSciences.
  •  LifeCell.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Stromal Vascular Fraction Market - By Type
1.3.2 Stromal Vascular Fraction Market - By Application
1.3.3 Stromal Vascular Fraction Market - By End-Users
1.3.4 Stromal Vascular Fraction Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. STROMAL VASCULAR FRACTION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. STROMAL VASCULAR FRACTION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. STROMAL VASCULAR FRACTION MARKET - GLOBAL MARKET ANALYSIS
6.1. STROMAL VASCULAR FRACTION - GLOBAL MARKET OVERVIEW
6.2. STROMAL VASCULAR FRACTION - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. STROMAL VASCULAR FRACTION MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. SVF ASPIRATE PURIFICATION PRODUCTS
7.3.1. Overview
7.3.2. SVF Aspirate Purification Products Market Forecast and Analysis
7.4. SVF TRANSFER PRODUCTS
7.4.1. Overview
7.4.2. SVF Transfer Products Market Forecast and Analysis
7.5. SVF ISOLATION PRODUCTS
7.5.1. Overview
7.5.2. SVF Isolation Products Market Forecast and Analysis
7.5.3. Enzymatic Isolation Products Market
7.5.3.1. Overview
7.5.3.2. Enzymatic Isolation Products Market Forecast and Analysis
7.5.4. Non-enzymatic Isolation Products Market
7.5.4.1. Overview
7.5.4.2. Non-enzymatic Isolation Products Market Forecast and Analysis
7.5.5. Automated POC Devices Market
7.5.5.1. Overview
7.5.5.2. Automated POC Devices Market Forecast and Analysis
8. STROMAL VASCULAR FRACTION MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. COSMETIC APPLICATIONS
8.3.1. Overview
8.3.2. Cosmetic Applications Market Forecast and Analysis
8.4. SOFT TISSUE APPLICATIONS
8.4.1. Overview
8.4.2. Soft Tissue Applications Market Forecast and Analysis
8.5. ORTHOPAEDIC APPLICATIONS
8.5.1. Overview
8.5.2. Orthopaedic Applications Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. STROMAL VASCULAR FRACTION MARKET - REVENUE AND FORECASTS TO 2027 - END-USERS
9.1. OVERVIEW
9.2. END-USERS MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. STEM CELL BANKS/LABORATORIES
9.4.1. Overview
9.4.2. Stem Cell Banks/Laboratories Market Forecast and Analysis
9.5. SPECIALTY CLINICS
9.5.1. Overview
9.5.2. Specialty Clinics Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis

10. STROMAL VASCULAR FRACTION MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Stromal Vascular Fraction Market Overview
10.1.2 North America Stromal Vascular Fraction Market Forecasts and Analysis
10.1.3 North America Stromal Vascular Fraction Market Forecasts and Analysis - By Type
10.1.4 North America Stromal Vascular Fraction Market Forecasts and Analysis - By Application
10.1.5 North America Stromal Vascular Fraction Market Forecasts and Analysis - By End-Users
10.1.6 North America Stromal Vascular Fraction Market Forecasts and Analysis - By Countries
10.1.6.1 Canada Stromal Vascular Fraction Market
10.1.6.1.1 Canada Stromal Vascular Fraction Market by Type
10.1.6.1.2 Canada Stromal Vascular Fraction Market by Application
10.1.6.1.3 Canada Stromal Vascular Fraction Market by End-Users
10.1.6.2 Mexico Stromal Vascular Fraction Market
10.1.6.2.1 Mexico Stromal Vascular Fraction Market by Type
10.1.6.2.2 Mexico Stromal Vascular Fraction Market by Application
10.1.6.2.3 Mexico Stromal Vascular Fraction Market by End-Users
10.1.6.3 US Stromal Vascular Fraction Market
10.1.6.3.1 US Stromal Vascular Fraction Market by Type
10.1.6.3.2 US Stromal Vascular Fraction Market by Application
10.1.6.3.3 US Stromal Vascular Fraction Market by End-Users
10.2. EUROPE
10.2.1 Europe Stromal Vascular Fraction Market Overview
10.2.2 Europe Stromal Vascular Fraction Market Forecasts and Analysis
10.2.3 Europe Stromal Vascular Fraction Market Forecasts and Analysis - By Type
10.2.4 Europe Stromal Vascular Fraction Market Forecasts and Analysis - By Application
10.2.5 Europe Stromal Vascular Fraction Market Forecasts and Analysis - By End-Users
10.2.6 Europe Stromal Vascular Fraction Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Stromal Vascular Fraction Market
10.2.6.1.1 Germany Stromal Vascular Fraction Market by Type
10.2.6.1.2 Germany Stromal Vascular Fraction Market by Application
10.2.6.1.3 Germany Stromal Vascular Fraction Market by End-Users
10.2.6.2 France Stromal Vascular Fraction Market
10.2.6.2.1 France Stromal Vascular Fraction Market by Type
10.2.6.2.2 France Stromal Vascular Fraction Market by Application
10.2.6.2.3 France Stromal Vascular Fraction Market by End-Users
10.2.6.3 Italy Stromal Vascular Fraction Market
10.2.6.3.1 Italy Stromal Vascular Fraction Market by Type
10.2.6.3.2 Italy Stromal Vascular Fraction Market by Application
10.2.6.3.3 Italy Stromal Vascular Fraction Market by End-Users
10.2.6.4 Spain Stromal Vascular Fraction Market
10.2.6.4.1 Spain Stromal Vascular Fraction Market by Type
10.2.6.4.2 Spain Stromal Vascular Fraction Market by Application
10.2.6.4.3 Spain Stromal Vascular Fraction Market by End-Users
10.2.6.5 United Kingdom Stromal Vascular Fraction Market
10.2.6.5.1 United Kingdom Stromal Vascular Fraction Market by Type
10.2.6.5.2 United Kingdom Stromal Vascular Fraction Market by Application
10.2.6.5.3 United Kingdom Stromal Vascular Fraction Market by End-Users
10.2.6.6 Rest of Europe Stromal Vascular Fraction Market
10.2.6.6.1 Rest of Europe Stromal Vascular Fraction Market by Type
10.2.6.6.2 Rest of Europe Stromal Vascular Fraction Market by Application
10.2.6.6.3 Rest of Europe Stromal Vascular Fraction Market by End-Users
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Stromal Vascular Fraction Market Overview
10.3.2 Asia-Pacific Stromal Vascular Fraction Market Forecasts and Analysis
10.3.3 Asia-Pacific Stromal Vascular Fraction Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Stromal Vascular Fraction Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Stromal Vascular Fraction Market Forecasts and Analysis - By End-Users
10.3.6 Asia-Pacific Stromal Vascular Fraction Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Stromal Vascular Fraction Market
10.3.6.1.1 Australia Stromal Vascular Fraction Market by Type
10.3.6.1.2 Australia Stromal Vascular Fraction Market by Application
10.3.6.1.3 Australia Stromal Vascular Fraction Market by End-Users
10.3.6.2 China Stromal Vascular Fraction Market
10.3.6.2.1 China Stromal Vascular Fraction Market by Type
10.3.6.2.2 China Stromal Vascular Fraction Market by Application
10.3.6.2.3 China Stromal Vascular Fraction Market by End-Users
10.3.6.3 India Stromal Vascular Fraction Market
10.3.6.3.1 India Stromal Vascular Fraction Market by Type
10.3.6.3.2 India Stromal Vascular Fraction Market by Application
10.3.6.3.3 India Stromal Vascular Fraction Market by End-Users
10.3.6.4 Japan Stromal Vascular Fraction Market
10.3.6.4.1 Japan Stromal Vascular Fraction Market by Type
10.3.6.4.2 Japan Stromal Vascular Fraction Market by Application
10.3.6.4.3 Japan Stromal Vascular Fraction Market by End-Users
10.3.6.5 South Korea Stromal Vascular Fraction Market
10.3.6.5.1 South Korea Stromal Vascular Fraction Market by Type
10.3.6.5.2 South Korea Stromal Vascular Fraction Market by Application
10.3.6.5.3 South Korea Stromal Vascular Fraction Market by End-Users
10.3.6.6 Rest of Asia-Pacific Stromal Vascular Fraction Market
10.3.6.6.1 Rest of Asia-Pacific Stromal Vascular Fraction Market by Type
10.3.6.6.2 Rest of Asia-Pacific Stromal Vascular Fraction Market by Application
10.3.6.6.3 Rest of Asia-Pacific Stromal Vascular Fraction Market by End-Users
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Stromal Vascular Fraction Market Overview
10.4.2 Middle East and Africa Stromal Vascular Fraction Market Forecasts and Analysis
10.4.3 Middle East and Africa Stromal Vascular Fraction Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Stromal Vascular Fraction Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Stromal Vascular Fraction Market Forecasts and Analysis - By End-Users
10.4.6 Middle East and Africa Stromal Vascular Fraction Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Stromal Vascular Fraction Market
10.4.6.1.1 South Africa Stromal Vascular Fraction Market by Type
10.4.6.1.2 South Africa Stromal Vascular Fraction Market by Application
10.4.6.1.3 South Africa Stromal Vascular Fraction Market by End-Users
10.4.6.2 Saudi Arabia Stromal Vascular Fraction Market
10.4.6.2.1 Saudi Arabia Stromal Vascular Fraction Market by Type
10.4.6.2.2 Saudi Arabia Stromal Vascular Fraction Market by Application
10.4.6.2.3 Saudi Arabia Stromal Vascular Fraction Market by End-Users
10.4.6.3 U.A.E Stromal Vascular Fraction Market
10.4.6.3.1 U.A.E Stromal Vascular Fraction Market by Type
10.4.6.3.2 U.A.E Stromal Vascular Fraction Market by Application
10.4.6.3.3 U.A.E Stromal Vascular Fraction Market by End-Users
10.4.6.4 Rest of Middle East and Africa Stromal Vascular Fraction Market
10.4.6.4.1 Rest of Middle East and Africa Stromal Vascular Fraction Market by Type
10.4.6.4.2 Rest of Middle East and Africa Stromal Vascular Fraction Market by Application
10.4.6.4.3 Rest of Middle East and Africa Stromal Vascular Fraction Market by End-Users
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Stromal Vascular Fraction Market Overview
10.5.2 South and Central America Stromal Vascular Fraction Market Forecasts and Analysis
10.5.3 South and Central America Stromal Vascular Fraction Market Forecasts and Analysis - By Type
10.5.4 South and Central America Stromal Vascular Fraction Market Forecasts and Analysis - By Application
10.5.5 South and Central America Stromal Vascular Fraction Market Forecasts and Analysis - By End-Users
10.5.6 South and Central America Stromal Vascular Fraction Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Stromal Vascular Fraction Market
10.5.6.1.1 Brazil Stromal Vascular Fraction Market by Type
10.5.6.1.2 Brazil Stromal Vascular Fraction Market by Application
10.5.6.1.3 Brazil Stromal Vascular Fraction Market by End-Users
10.5.6.2 Argentina Stromal Vascular Fraction Market
10.5.6.2.1 Argentina Stromal Vascular Fraction Market by Type
10.5.6.2.2 Argentina Stromal Vascular Fraction Market by Application
10.5.6.2.3 Argentina Stromal Vascular Fraction Market by End-Users
10.5.6.3 Rest of South and Central America Stromal Vascular Fraction Market
10.5.6.3.1 Rest of South and Central America Stromal Vascular Fraction Market by Type
10.5.6.3.2 Rest of South and Central America Stromal Vascular Fraction Market by Application
10.5.6.3.3 Rest of South and Central America Stromal Vascular Fraction Market by End-Users

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. STROMAL VASCULAR FRACTION MARKET, KEY COMPANY PROFILES
12.1. CYTORI THERAPEUTICS
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. CELLULAR BIOMEDICINE GROUP, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. GE HEALTHCARE
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. MEDIKAN INTERNATIONAL
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. INGENERON
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. TISSUE GENESIS
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. GENESIS BIOSYSTEMS
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. HUMAN MED
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. INTELLICELL BIOSCIENCES
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. LIFECELL
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Cytori Therapeutics
2. Cellular Biomedicine Group, Inc.
3. GE Healthcare
4. Medikan International
5. Ingeneron
6. Tissue Genesis
7. Genesis Biosystems
8. Human Med
9. IntelliCell BioSciences
10. LifeCell
TIPRE00021191
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking